About: Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 December 2019

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • im Dezember 2019 veröffentlichter wissenschaftlicher Artikel (de)
  • artículu científicu espublizáu n'avientu de 2019 (ast)
  • 2019 թվականի դեկտեմբերի 12-ին հրատարակված գիտական հոդված (hy)
  • scientific article published on 12 December 2019 (en)
  • наукова стаття, опублікована 12 грудня 2019 (uk)
publication date
publication date
author name string
author name string
  • Jan Borén
  • Martin Adiels
  • Paolo Parini
  • Kimmo Porthan
  • Antti Hakkarainen
  • Marcus Ståhlman
  • Linda Andersson
  • Elias Björnson
  • Sanni Söderlund
  • Juhani Kahri
  • Chris Packard
  • Niina Matikainen
  • Ralf Nilsson
  • Kirsi Pietiläinen
rdfs:label
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (en)
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (nl)
skos:prefLabel
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (en)
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (nl)
name
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (en)
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (nl)
author
author
title
title
  • Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects (en)
page(s)
page(s)
  • 77-87
instance of
instance of
PubMed ID
PubMed ID
PubMed ID
  • 31917184
published in
published in
issue
volume
issue
  • 1
volume
  • 14
DOI
DOI
DOI
  • 10.1016/J.JACL.2019.12.003
is about of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software